Evaluation of Two Modified Cardiac Troponin I Enzyme Immunoassays
-
Cornelia Haug
Abstract
One of the major challenges for manufacturers of troponin immunoassays is to optimize the low-end of the assays because diagnostic and therapeutic interventions are based on decreasing cutpoints. Recently published consensus documents of the European Society of Cardiology and the American College of Cardiology recommended the 99th percentile of a reference control group as cut-off for increased troponin I levels and suggested that imprecision at the 99th percentile for each assay should be ≤10%. In this study, we have evaluated two newly modified cardiac troponin I (cTnI) enzyme immunoassays (Dimension® cTnI assay, Dade Behring, Germany and AIA-PACK cTnI 2nd-Gen, Eurogenetics Tosoh, Belgium). With both assays all measured cTnI values in plasma and serum samples of apparently healthy volunteers were within the reference ranges given by the manufacturers. Intra-assay coefficients of variation of cTnI concentrations above the 99th percentile (given by the manufacturers) were below 17% and decreased with increasing cTnI concentrations. In most samples, the AIA-PACK cTnI assay yielded higher results; however, a close correlation between both assays was observed. Both tests exhibit acceptable overall performance, but (especially the Dimension ® cTnI assay) do not yet meet the above-mentioned precision in the low-end assay range. These data emphasize the need for cTnI assay standardization and for further optimization at clinical decision levels.
Copyright © 2002 by Walter de Gruyter GmbH & Co. KG
Articles in the same Issue
- SIBioC 2002 - 34th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology, Rimini, Italy, 17-20 September 2002
- Santorini Biologie Prospective Conference 2002 From Genetic Variations to Risk Prediction and Pharmacogenomics Santorini, Greece, 25-28 September 2002
- CCLM Special Issue on Diabetes Mellitus - Call for Papers
- Pathophysiological and Clinical Relevance of Circulating Levels of Cardiac Natriuretic Hormones: Are They Merely Markers of Cardiac Disease?
- Comparative Measurement of N-Terminal Pro-Brain Natriuretic Peptide and Brain Natriuretic Peptide in Ambulatory Patients with Heart Failure
- Tumor Necrosis Factor-α-Induced Accumulation of Tumor Suppressor Protein p53 and Cyclin-dependent Protein Kinase Inhibitory Protein p21 Is Inhibited by Insulin in ME-180S Cells
- Inflammatory Response to Coronary Stent Implantation in Patients with Unstable Angina
- Immature Granulocyte Count after Liver Transplantation
- An Ideal Substrate for the Measurement of Pancreatic Amylase?
- Defining the Period of Recovery of the Glucose Concentration after Its Local Perturbation by the Implantation of a Miniature Sensor
- Measurement of Serum β-Crosslaps Is Influenced by Proteolytic Conditions
- Quantitative Determination of Faecal Fatty Acids and Triglycerides by Fourier Transform Infrared Analysis with a Sodium Chloride Transmission Flow Cell
- Rapid Identification of Atypical Variant of Plasma Butyrylcholinesterase by PCR
- Determination of Nitrite Plus Nitrate and Malondialdehyde in Human Plasma: Analytical Performance and the Effect of Smoking and Exercise
- Iron Status in Black Persons Is Not Influenced by Haptoglobin Polymorphism
- Molecular Characterization of Glucose-6-Phosphate Dehydrogenase Deficiency in the Eastern Province of Saudi Arabia
- Comparison of Urine Cell Characteristics by Flow Cytometry and Cytology in Patients Suspected of Having Bladder Cancer
- Clinical Validation of a Fully Automated 17β-Estradiol and Progesterone Assay (VIDAS®) for Use in Monitoring Assisted Reproduction Treatment
- Evaluation of a Commercially Available Serologic Assay for Antibodies against Tuberculosis-associated Glycolipid Antigen
- Evaluation of Two Modified Cardiac Troponin I Enzyme Immunoassays
- Evaluation of Denka-Seiken Turbidimetric High-Sensitivity C-Reactive Protein Assay
- Amiodarone and Desethylamiodarone Bind to Barrier Gels in Serum Separator Blood Collection Tubes
- A Novel Explanation for Low Alanine Aminotransferase Activity in Human Serum Caused by IgG Inhibitor
- Serum Total Antioxidant Status Is Higher in Postmenopausal Women and after Estrogen Replacement Therapy
- Immunoturbidimetric Assay for Serum Cystatin C Using the Cobas Fara Analyzer
- Meetings and Awards
Articles in the same Issue
- SIBioC 2002 - 34th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology, Rimini, Italy, 17-20 September 2002
- Santorini Biologie Prospective Conference 2002 From Genetic Variations to Risk Prediction and Pharmacogenomics Santorini, Greece, 25-28 September 2002
- CCLM Special Issue on Diabetes Mellitus - Call for Papers
- Pathophysiological and Clinical Relevance of Circulating Levels of Cardiac Natriuretic Hormones: Are They Merely Markers of Cardiac Disease?
- Comparative Measurement of N-Terminal Pro-Brain Natriuretic Peptide and Brain Natriuretic Peptide in Ambulatory Patients with Heart Failure
- Tumor Necrosis Factor-α-Induced Accumulation of Tumor Suppressor Protein p53 and Cyclin-dependent Protein Kinase Inhibitory Protein p21 Is Inhibited by Insulin in ME-180S Cells
- Inflammatory Response to Coronary Stent Implantation in Patients with Unstable Angina
- Immature Granulocyte Count after Liver Transplantation
- An Ideal Substrate for the Measurement of Pancreatic Amylase?
- Defining the Period of Recovery of the Glucose Concentration after Its Local Perturbation by the Implantation of a Miniature Sensor
- Measurement of Serum β-Crosslaps Is Influenced by Proteolytic Conditions
- Quantitative Determination of Faecal Fatty Acids and Triglycerides by Fourier Transform Infrared Analysis with a Sodium Chloride Transmission Flow Cell
- Rapid Identification of Atypical Variant of Plasma Butyrylcholinesterase by PCR
- Determination of Nitrite Plus Nitrate and Malondialdehyde in Human Plasma: Analytical Performance and the Effect of Smoking and Exercise
- Iron Status in Black Persons Is Not Influenced by Haptoglobin Polymorphism
- Molecular Characterization of Glucose-6-Phosphate Dehydrogenase Deficiency in the Eastern Province of Saudi Arabia
- Comparison of Urine Cell Characteristics by Flow Cytometry and Cytology in Patients Suspected of Having Bladder Cancer
- Clinical Validation of a Fully Automated 17β-Estradiol and Progesterone Assay (VIDAS®) for Use in Monitoring Assisted Reproduction Treatment
- Evaluation of a Commercially Available Serologic Assay for Antibodies against Tuberculosis-associated Glycolipid Antigen
- Evaluation of Two Modified Cardiac Troponin I Enzyme Immunoassays
- Evaluation of Denka-Seiken Turbidimetric High-Sensitivity C-Reactive Protein Assay
- Amiodarone and Desethylamiodarone Bind to Barrier Gels in Serum Separator Blood Collection Tubes
- A Novel Explanation for Low Alanine Aminotransferase Activity in Human Serum Caused by IgG Inhibitor
- Serum Total Antioxidant Status Is Higher in Postmenopausal Women and after Estrogen Replacement Therapy
- Immunoturbidimetric Assay for Serum Cystatin C Using the Cobas Fara Analyzer
- Meetings and Awards
